Sign in

CIK 0001635077 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Aclarion, Inc.

Sign in to watch
Ticker
ACON
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
473324725
Phone
833 275 2266
Business address
8181 ARISTA PLACE, STE 100, BROOMFIELD, CO, 80021
Former names
Nocimed, Inc.

Securities

  • ACON Common Stock Nasdaq
  • ACONW Warrant Nasdaq
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Other disposition Executive Chairman disposed of 1 shares (other)
  4. 4 Open-market buy Executive Chairman bought 1 shares at $1,000.00 ($1,000)
  5. 4 Open-market buy Chief Executive Officer bought 18,500 shares at an average $0.53 ($9,769)
  6. 4 Open-market buy Chief Financial Officer bought 22,404.44 shares at an average $0.45 ($10,000)
  7. 4 Derivatives Options or other derivatives
  8. 4/A Other acquisition Director acquired 152,128 shares (other)
  9. 4 Other disposition Former 10% Owner disposed of 1,091,894 shares (other)
  10. 4 Other disposition Director disposed of 152,128 shares (other)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 3/A Insider 3/A
  15. 3/A Insider 3/A
  16. 4 Open-market buy Chief Strategy Officer bought 20,000 shares at $2.80 ($56,000)
  17. 4 Open-market buy Director bought 11,000 shares at $4.35 ($47,850)
  18. 3/A Insider 3/A
  19. 4 Open-market buy Chief Executive Officer bought 1,000 shares at $4.35 ($4,350)
  20. 4 Open-market buy Director bought 34,400 shares at $4.35 ($149,640)

Page 2 of 3 · 54 filings